Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined -10.05%, underperforming the MSCI ACWI Index and the MSCI ACWI Value Index, which returned -6.82% and -7.66%, respectively. Multiple headwinds from all over the world affected the fund’s performance in the quarter. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.
Ariel Investment highlighted stocks like Haleon plc (NYSE:HLN) in its Q3 2022 investor letter. Headquartered in Brentford, the United Kingdom, Haleon plc (NYSE:HLN) is a healthcare products company. On December 2, 2022, Haleon plc (NYSE:HLN) stock closed at $7.15 per share. One-month return of Haleon plc (NYSE:HLN) was 11.37%, and in three months its shares gained 27.00% of their value. Haleon plc (NYSE:HLN) has a market capitalization of $33.014 billion.
Ariel Investment made the following comment about Haleon plc (NYSE:HLN) in its Q3 2022 investor letter:
"We initiated two new positions in the quarter. We added British multinational consumer healthcare company Haleon plc (NYSE:HLN) following its spin-off from longtime holding, GSK plc. The company’s world-class portfolio of health brands is delivering double-digit organic revenue growth and margin expansion across channels and geographies. We continue to see potential for significant incremental value creation from a more focused and independent consumer health franchise in the years ahead."
Haleon plc (NYSE:HLN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held Haleon plc (NYSE:HLN) at the end of the third quarter, which was 0 in the previous quarter.
We discussed Haleon plc (NYSE:HLN) in another article and shared Aristotle Capital’s views on the company. In addition, please check out our hedge fund investor letters Q3 2022 page for more investor letters from hedge funds and other leading investors.
Disclosure: None. This article is originally published at Insider Monkey.